Corticosteroid use in ARDS and its application to evolving therapeutics for coronavirus disease 2019 (COVID‐19): A systematic review-Reference-Cited by-同舟云学术

Corticosteroid use in ARDS and its application to evolving therapeutics for coronavirus disease 2019 (COVID‐19): A systematic review

Published:2021-10-28 Issue:1 Volume:42 Page:71-90
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Landolf Kaitlin M.¹^ORCID,Lemieux Steven M.²,Rose Christina³,Johnston Jackie P.⁴^ORCID,Adams Christopher D.⁴,Altshuler Jerry⁵,Berger Karen⁶^ORCID,Dixit Deepali⁴,Effendi Muhammad K.⁴,Heavner Mojdeh S.¹^ORCID,Lemieux Diana⁷,Littlefield Audrey J.⁶,Nei Andrea M.⁸,Owusu Kent A.⁷⁹,Rinehart Marisa¹,Robbins Blake¹⁰,Rouse Ginger E.⁷,Thompson Bastin Melissa L.¹⁰^ORCID

Affiliation:

1. Department of Pharmacy Practice and Science University of Maryland School of Pharmacy Baltimore Maryland USA

2. Department of Pharmacy VA Connecticut Healthcare System West Haven Connecticut USA

3. Department of Pharmacy Practice Temple University School of Pharmacy Philadelphia Pennsylvania USA

4. Department of Pharmacy Practice and Administration Ernest Mario School of Pharmacy Piscataway New Jersey USA

5. Department of Pharmacy Hackensack Meridian Health JFK University Medical Center Edison New Jersey USA

6. Department of Pharmacy New York‐Presbyterian Hospital/Weill Cornell Medical Center New York New York USA

7. Department of Pharmacy Services Yale New Haven Hospital New Haven Connecticut USA

8. Department of Pharmacy Mayo Clinic Hospital – Rochester Rochester Minnesota USA

9. Care Signature Yale New Haven Health New Haven Connecticut USA

10. Department of Pharmacy Services University of Kentucky HealthCare Lexington Kentucky USA

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/phar.2637

Reference82 articles.

1. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries

2. Acute Respiratory Distress Syndrome

3. Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey

4. Comparing Clinical Features and Outcomes in Mechanically Ventilated Patients with COVID-19 and Acute Respiratory Distress Syndrome

5. Diffuse alveolar damage (DAD) resulting from coronavirus disease 2019 Infection is Morphologically Indistinguishable from Other Causes of DAD

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemical pneumonitis secondary to accidental pulmonary polyethylene glycol–electrolyte solution infusion in a cat;Journal of Veterinary Emergency and Critical Care;2024-05

2. Glucocorticoid use in acute respiratory failure from pulmonary causes and association with early changes in the systemic host immune response;Intensive Care Medicine Experimental;2024-03-05

3. Investigational pharmacological agents for the treatment of ARDS;Expert Opinion on Investigational Drugs;2024-02-27

4. Use of Additional Corticosteroids in Nonresolving COVID-19–Associated Acute Respiratory Distress Syndrome: A Resolved Issue?*;Critical Care Medicine;2023-09-14

5. Inhaled lipid nanocarriers for pulmonary delivery of glucocorticoids: Previous strategies, recent advances and key factors description;International Journal of Pharmaceutics;2023-07